All participants included in this study were devoid of any systemic comorbidities, such as diabetes, renal disease, hypertension, and diseases affecting bone hemostasis, such as disorders in vitamin D, parathyroid, and growth hormone. This evidence concerns the gene GH1 and diabetes mellitus.